Stryker Corp
Chiusa
SettoreSettore sanitario
314.1 1.54
Panoramica
Variazione del prezzo dell'azione
24h
Minimo
309.91
Massimo
319.02
Entrata | -104M 745M |
|---|---|
Vendite | -1.2B 6B |
P/E Media del settore | 35.224 50.958 |
EPS | 2.6 |
Rendimento da dividendi | 1.12 |
Margine di Profitto | 12.375 |
Dipendenti | 56,000 |
EBITDA | -416M 1.3B |
Raccomandazioni | Fortemente da comprare |
|---|---|
Previsioni per 12 mesi | +25.24% upside |
Rendimento da dividendi Media del settore | 1.12% 2.41% |
|---|---|
Utili prossimi | 30 lug 2026 |
Prossima data del Dividendo | 31 lug 2026 |
Prossima data del' Ex Dividendo | 30 giu 2026 |
Capitalizzazione di Mercato | -9.2B 117B |
|---|---|
Apertura precedente | 312.56 |
Chiusura precedente | 314.1 |
Notizie sul Sentiment di mercato
By Acuity
54%
46%
273 / 342 Classifica in Healthcare
Stryker Corp Grafico
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
Chi Siamo Stryker Corp
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.